🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of Tylenol, asserting the firms hid safety concerns that the medication created to children's neurological development.

This legal action comes four weeks after Former President Trump promoted an unverified association between taking Tylenol - referred to as acetaminophen - during pregnancy and autism in offspring.

The attorney general is filing suit against the pharmaceutical giant, which once produced the drug, the exclusive pain medication recommended for expectant mothers, and Kenvue, which now manufacturers it.

In a official comment, he said they "deceived the public by making money from suffering and marketing drugs regardless of the risks."

The company asserts there is no credible evidence connecting acetaminophen to autism.

"These manufacturers misled for generations, deliberately risking millions to line their pockets," Paxton, from the Republican party, stated.

Kenvue commented that it was "seriously troubled by the dissemination of inaccurate information on the security of paracetamol and the likely effects that could have on the welfare of American women and children."

On its website, the company also mentioned it had "consistently assessed the pertinent research and there is lacking reliable evidence that shows a verified association between taking acetaminophen and autism spectrum disorder."

Groups representing doctors and health professionals agree.

ACOG has declared paracetamol - the main ingredient in Tylenol - is one of the few options for women during pregnancy to address discomfort and elevated temperature, which can present significant medical dangers if not addressed.

"In multiple decades of investigation on the use of paracetamol in gestation, not a single reputable study has conclusively proven that the use of acetaminophen in any stage of pregnancy results in neurodevelopmental disorders in children," the group said.

The lawsuit cites recent announcements from the former administration in asserting the drug is reportedly hazardous.

Last month, Trump caused concern from medical authorities when he instructed pregnant women to "resist strongly" not to consume Tylenol when ill.

Federal regulators then released a statement that physicians should think about restricting the usage of acetaminophen, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in minors has not been proven.

Health Secretary RFK Jr, who supervises the FDA, had promised in spring to initiate "comprehensive study program" that would identify the cause of autism spectrum disorder in a matter of months.

But experts cautioned that identifying a sole reason of autism - considered by experts to be the consequence of a complicated interplay of genetic and surrounding conditions - would not be simple.

Autism is a category of permanent neurological difference and condition that impacts how persons perceive and relate to the surroundings, and is identified using medical professional evaluations.

In his legal document, the attorney general - who supports Trump who is running for federal office - alleges Kenvue and J&J "intentionally overlooked and tried to quiet the evidence" around paracetamol and autism.

This legal action aims to force the companies "destroy any marketing or advertising" that claims acetaminophen is safe for women during pregnancy.

The Texas lawsuit echoes the complaints of a collection of mothers and fathers of children with autism and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in recently.

The court dismissed the legal action, stating research from the family's specialists was lacking definitive proof.